Shivalik Rasayan Limited — Important, 14-11-2024: Financial Result Updates

Shivalik Rasayan has announced a board meeting with the following key financial metrics for the quarter and half-year ended September 30, 2024.

Total revenue reached ₹150 crore, reflecting a robust year-over-year growth of 25%. This surge can be attributed to increased demand in both the agrochemical and pharmaceutical sectors, as well as successful market penetration strategies.

Net profit stood at ₹30 crore, marking a significant improvement from ₹20 crore in the previous year, resulting in an EPS of ₹6. The increase in profitability can be linked to efficient cost management alongside rising revenues. Operational costs rose by 10%, primarily due to elevated raw material prices and expansion-related investments. However, the company has maintained its cost efficiency, showcasing its capability to manage increased operating expenses effectively.

The balance sheet indicates a healthy liquidity position, with cash and cash equivalents growing by 15% to ₹50 crore. The reduction of debt has further improved the financial stability of the company.

Strategically, Shivalik is positioned for growth with initiatives focused on expanding its API offerings and increasing agrochemical production capacity. The commissioning of new plants and product development will likely drive future performance.

Considering the current financial performance, cost management, and strategic focus on innovation and market expansion, Shivalik Rasayan presents a buy insight for investors.